Upregulation of LAMP3 expression acts as a biomarker for poor prognosis in oesophageal squamous cell carcinoma (ESCC) and ovarian cancer [149,150], whereas downregulation of LAMP3 expression has been associated with poor prognosis in hepatocellular carcinoma [151]. The gene discussed is LAMP3; the disease is esophageal squamous cell carcinoma.